Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Nature Reviews. Urology
|
November 3, 2011
Complications associated with urinary diversion
Richard E Hautmann, Stefan H Hautmann, Oliver Hautmann
The Journal of Urology
|
July 20, 2002
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests
Martin G Friedrich, Angelika Hellstern, Stefan H Hautmann, et al.
World Journal of Urology
|
March 3, 2004
Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer
Marieta I Toma, Martin G Friedrich, Stefan H Hautmann, et al.
The Journal of Urology
|
August 18, 2004
A side by side comparison of cytology and biomarkers for bladder cancer detection
Grethchen L Schroeder, Maria-Fernanda Lorenzo-Gomez, Stefan H Hautmann, et al.
International Journal of Cancer
|
January 19, 2007
HAS1 expression in bladder cancer and its relation to urinary HA test
Roozbeh Golshani, Stefan H Hautmann, Veronica Estrella, et al.
Cancer
|
July 13, 2002
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests
Vinata B Lokeshwar, Grethchen L Schroeder, Marie G Selzer, et al.
Urology
|
January 10, 2006
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
Tomonori Habuchi, Michael Marberger, Michael J Droller, et al.
Urology
|
January 10, 2006
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Vinata B Lokeshwar, Tomonori Habuchi, H Barton Grossman, et al.
European Urology
|
September 22, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion
Richard E Hautmann, Hassan Abol-Enein, Thomas Davidsson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Nature Reviews. Urology
|
November 3, 2011
Complications associated with urinary diversion
Richard E Hautmann, Stefan H Hautmann, Oliver Hautmann
The Journal of Urology
|
July 20, 2002
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests
Martin G Friedrich, Angelika Hellstern, Stefan H Hautmann, et al.
World Journal of Urology
|
March 3, 2004
Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer
Marieta I Toma, Martin G Friedrich, Stefan H Hautmann, et al.
The Journal of Urology
|
August 18, 2004
A side by side comparison of cytology and biomarkers for bladder cancer detection
Grethchen L Schroeder, Maria-Fernanda Lorenzo-Gomez, Stefan H Hautmann, et al.
International Journal of Cancer
|
January 19, 2007
HAS1 expression in bladder cancer and its relation to urinary HA test
Roozbeh Golshani, Stefan H Hautmann, Veronica Estrella, et al.
Cancer
|
July 13, 2002
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests
Vinata B Lokeshwar, Grethchen L Schroeder, Marie G Selzer, et al.
Urology
|
January 10, 2006
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
Tomonori Habuchi, Michael Marberger, Michael J Droller, et al.
Urology
|
January 10, 2006
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Vinata B Lokeshwar, Tomonori Habuchi, H Barton Grossman, et al.
European Urology
|
September 22, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion
Richard E Hautmann, Hassan Abol-Enein, Thomas Davidsson, et al.
Page
of 1